Dailypharm Live Search Close

High-priced drugs need adjustment from the approval stage

By Lee, Tak-Sun | translator Kim, Jung-Ju

23.09.15 14:30:56

가나다라 0
Participation in the NHIS and Pharmaceutical Evaluation Committee helps reduce insurance finances... Pursuing sustainability

NHIS Chairman Jeong Ki-seok (65) emphasized that rising drug prices are an inevitable phenomenon and that adjustments must be made starting from the domestic approval stage


He also explained that he would conduct a pilot project to curb multi-drug prescriptions to reduce usage. Chairman Jeong made this announcement at a press conference for a health magazine held at a restaurant in Gwanghwamun, Seoul on the 15th. He said, “It is true that as income increases, prescriptions switch to more expensive drugs even if they have similar efficacy.” He said, “Moreover, doctors prefer original drugs with extensive research rather than generic drugs that have only received BA evaluation.”

He said, "The authorities are continuing to set prices for generic drugs and are using a savings policy of refunding half of the money after verifying the efficacy of expensive drugs for a year,

Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)